Sussex Partner Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
      • Blood and blood-forming organs
      • 9.1 Anaemias
      • 9.2 Iron overload
      • 9.3 Neutropenia and stem cell mobilisation
      • 9.4 Platelet disorders
      • Nutrition and metabolic disorders
      • 9.5 Fluid and electrolyte imbalances
      • 9.6 Metabolic disorders
      • 9.7 Mineral and trace elements deficiencies
      • 9.8 Nutrition (intravenous)
      • 9.9 Nutrition (oral)
      • 9.10 Vitamin deficiency
      • 9.11 Other Blood and nutrition items
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Additrace

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For Refeeding syndrome - Use as per 10-day refeeding protocol (see Refeeding syndrome | Items agreed for prescribing to prevent or manage refeeding syndrome)  as per NICE CG32

Additrace concentrate for solution for infusion 10ml ampoules

Pack
20 ampoule
1 ampoule

Cernevit

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For Refeeding syndrome - Use as per 10-day refeeding protocol (see Refeeding syndrome | Items agreed for prescribing to prevent or manage refeeding syndrome)  as per NICE CG32

Cernevit powder for solution for injection vials

Pack
10 vial

Nutratain

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For Refeeding syndrome - Refeeding syndrome | Items agreed for prescribing to prevent or manage refeeding syndrome as per NICE CG32

Generic Nutratain 932mg powder for solution for infusion vials

Pack
10 vial

Nutryelt

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For Refeeding syndrome - Refeeding syndrome | Items agreed for prescribing to prevent or manage refeeding syndrome as per NICE CG32

Generic Nutryelt concentrate for solution for infusion 10ml ampoules

Pack
10 ampoule
1 ampoule

Sodium glycerophosphate

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For Refeeding syndrome - Use as per 10-day refeeding protocol (see Refeeding syndrome | Items agreed for prescribing to prevent or manage refeeding syndrome)  as per NICE CG32

Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules

Pack
1 ampoule
20 ampoule

Sodium glycerophosphate 4.32g/20ml solution for infusion vials

Pack
1 vial
10 vial

Sodium glycerophosphate 10.8g/50ml solution for infusion vials

Pack
1 vial
10 vial

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2025